Showing results (51-60 of 229) with videos related to
Sort By:
Pageof 23
World Journal of Gastroenterology|August 18, 2022
Patient-derived organoids for therapy personalization in inflammatory bowel diseasesMarianna Lucafò, Antonella Muzzo, Martina Marcuzzi, et al.The International Journal of Biological Markers|May 24, 2014
A pharmacogenetic survey of androgen receptor (CAG)n and (GGN)n polymorphisms in patients experiencing long term side effects after finasteride discontinuationErika Cecchin, Elena De Mattia, Giorgio Mazzon, et al.Frontiers in Immunology|May 31, 2021
Gender May Influence the Immunosuppressive Actions of Prednisone in Young Patients With Inflammatory Bowel DiseaseMarianna Lucafò, Matteo Bramuzzo, Davide Selvestrel, et al.Antibiotics (Basel, Switzerland)|July 27, 2024
Preanalytical Stability of 13 Antibiotics in Biological Samples: A Crucial Factor for Therapeutic Drug MonitoringPaolo Dalla Zuanna, Debora Curci, Marianna Lucafò, et al.Current Medicinal Chemistry|December 9, 2021
Extracellular Vesicles as Innovative Tools for Assessing Adverse Effects of Immunosuppressant DrugsMarianna Lucafò, Serena De Biasi, Debora Curci, et al.International Journal of Molecular Sciences|November 8, 2019
Circulating-Free DNA Analysis in Hepatocellular Carcinoma: A Promising Strategy to Improve Patients' Management and Therapy OutcomesSilvia Mezzalira, Elena De Mattia, Michela Guardascione, et al.Cancer Drug Resistance (Alhambra, Calif.)|May 18, 2022
The use of pharmacogenetics to increase the safety of colorectal cancer patients treated with fluoropyrimidinesElena De Mattia, Rossana Roncato, Chiara Dalle Fratte, et al.Oncology Reports|July 16, 2004
UGT1A1*28 polymorphism in ovarian cancer patientsErika Cecchin, Antonio Russo, Giuseppe Corona, et al.Sexual Medicine|December 28, 2016
Androgen Receptor (AR) Gene (CAG)n and (GGN)n Length Polymorphisms and Symptoms in Young Males With Long-Lasting Adverse Effects After Finasteride Use Against Androgenic AlopeciaSabina Cauci, Giovanni Chiriacò, Erika Cecchin, et al.Journal of Personalized Medicine|June 24, 2022
Atomic Force Microscopy Application for the Measurement of Infliximab Concentration in Healthy Donors and Pediatric Patients with Inflammatory Bowel DiseaseDebora Curci, Marianna Lucafò, Pietro Parisse, et al.Pageof 23